Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study. (academic.oup.com)

Authors: Calabrese C … Wang XF Journal: Clinical Infectious Diseases Published: 2026-02-04 DOI: https://doi.org/10.1093/cid/ciaf521